9 out of 10 based on 938 ratings. 4,495 user reviews.

# GAUSS EXAM 2013 TRIAL

Efficacy and Tolerability of Evolocumab vs Ezetimibe in
Apr 19, 2016To our knowledge, the GAUSS-3 trial represents the largest and most comprehensive study using a blinded rechallenge procedure to assess the ability of patients with a history of muscle-related adverse effects to tolerate statins. The trial provides insights into the time course of statin-associated muscle-related adverse effects.Cited by: 275Publish Year: 2016Author: Steven E. Nissen, Erik Stroes, Ricardo E. Dent-Acosta, Robert S. Rosenson, Sam J. Lehman, Naveed Sat..[PDF]
2013 Gauss Contests - CEMC
2013 Gauss Contest Solutions Page 3 Grade 7 1. Evaluating, (5 3) 2 = 15 2 = 13: Answer: (E) 2. Solution 1 A number is a multiple of 9 if it is the result of multiplying 9 by an integer. Of the answers given, only 45 results from multiplying 9 by an integer, since 45 = 9 5. Solution 2
Design and rationale of the GAUSS-2 study trial: a double
Design and rationale of the GAUSS-2 study trial: a double-blind, ezetimibe-controlled phase 3 study of the efficacy and tolerability of evolocumab (AMG 145) in subjects with hypercholesterolemia who are intolerant of statin therapy. Cho L(1), Rocco M, Colquhoun D, Sullivan D, Rosenson RS, Dent R, Xue A, Scott R, Wasserman SM, Stroes E.Cited by: 22Publish Year: 2014Author: Leslie Cho, Michael Rocco, David Colquhoun, David Sullivan, Robert S. Rosenson, Ricardo Dent, Allen
Efficacy and Tolerability of Evolocumab vs Ezetimibe in
Apr 19, 2016Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance: The GAUSS-3 Randomized Clinical Trial. (LDL-C) levels and history of intolerance to 2 or more statins enrolled in 2013 and 2014 globally. Phase A used a 24-week crossover procedure with atorvastatin or placebo to identify patients havingPublished in: JAMA · 2016Authors: Steven E Nissen · Erik S G Stroes · Ricardo E Dentacosta · Robert S Rosenson · SaAffiliation: Cleveland Clinic · University of Amsterdam · Amgen · Mount Sinai Hospital · Flinders About: Atorvastatin calcium · Hydroxymethylglutaryl-CoA Reductase Inhibitors · Myositis · PC
Goal Achievement After Utilizing an Anti-PCSK9 Antibody in
Jan 09, 2013Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin Intolerant Subjects -2 (GAUSS-2) 2013: Actual Primary Completion Date : November 19, 2013 Rosenson RS, Dent R, Xue A, Scott R, Wasserman SM, Stroes E. Design and rationale of the GAUSS-2 study trial: a double-blind, ezetimibe-controlled phase 3 study of the efficacy and
GAUSS: A Study of Obinutuzumab (RO5072759) in Patients
Dec 19, 2007GAUSS: A Study of Obinutuzumab (RO5072759) in Patients With Indolent Non-Hodgkin's Lymphoma The safety and scientific validity of this study is the responsibility of
GAUSS-3: Evolocumab Cuts LDL-C in Statin-Intolerant Patients
Oct 24, 2019In 2014, as reported by heartwire, Amgen announced that statin-intolerant patients in the GAUSS-2 trial had significantly lowered LDL-C levels after receiving evolocumab for
CEMC - Past Contests - Mathematics and Computing Contests
Problems, solutions and results dating back to 1998 can be found in the chart below. For the Gauss, Pascal, Cayley, and Fermat Contests, the CEMC problem set generator can be used to create sets of past problems with customized topics.[PDF]
2014 Gauss Contests - CEMC
2014 Gauss Contests (Grades 7 and 8) Wednesday, May 14, 2014 (in North America and South America) Thursday, May 15, 2014 (outside of North America and South America) Solutions ©2013 University of Waterloo[PDF]
AP Physics Practice Test: Electric Forces & Fields, Gauss
AP Physics Practice Test: Electric Forces & Fields, Gauss’s Law, Potential ©2013, Richard White wwwhwhite c. Identify the total amount of charge induced on the inner surface of the conducting shell, at radius b. d.